SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-005934
Filing Date
2017-09-19
Accepted
2017-09-18 21:44:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2233325z424b5.htm 424B5 629492
2 G1013571.JPG g1013571.jpg GRAPHIC 18917
3 G925023.JPG g925023.jpg GRAPHIC 81785
  Complete submission text file 0001047469-17-005934.txt   769547
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-219567 | Film No.: 171091011
SIC: 2834 Pharmaceutical Preparations